As of Apr 24
| -0.02 / -0.75%|
The 6 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 3.75, with a high estimate of 4.50 and a low estimate of 3.25. The median estimate represents a +41.51% increase from the last price of 2.65.
The current consensus among 6 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.